Generation of iPSCs from cultured human malignant cells

被引:169
作者
Carette, Jan E.
Pruszak, Jan [2 ]
Varadarajan, Malini
Blomen, Vincent A.
Gokhale, Sumita
Camargo, Fernando D.
Wernig, Marius
Jaenisch, Rudolf [3 ]
Brummelkamp, Thijn R. [1 ]
机构
[1] Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA
[2] Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02178 USA
[3] MIT, Dept Biol, Cambridge, MA 02139 USA
关键词
PLURIPOTENCY; CANCER; MOUSE; MYC;
D O I
10.1182/blood-2009-07-231845
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Induced pluripotent stem cells (iPSCs) can be generated from various differentiated cell types by the expression of a set of defined transcription factors. So far, iPSCs have been generated from primary cells, but it is unclear whether human cancer cell lines can be reprogrammed. Here we describe the generation and characterization of iPSCs derived from human chronic myeloid leukemia cells. We show that, despite the presence of oncogenic mutations, these cells acquired pluripotency by the expression of 4 transcription factors and underwent differentiation into cell types derived of all 3 germ layers during teratoma formation. Interestingly, although the parental cell line was strictly dependent on continuous signaling of the BCR-ABL oncogene, also termed oncogene addiction, reprogrammed cells lost this dependency and became resistant to the BCR-ABL inhibitor imatinib. This finding indicates that the therapeutic agent imatinib targets cells in a specific epigenetic differentiated cell state, and this may contribute to its inability to fully eradicate disease in chronic myeloid leukemia patients. (Blood. 2010; 115(20): 4039-4042)
引用
收藏
页码:4039 / 4042
页数:4
相关论文
共 16 条
[1]   Broader Implications of Defining Standards for the Pluripotency of iPSCs [J].
Daley, George Q. ;
Lensch, M. William ;
Jaenisch, Rudolf ;
Meissner, Alex ;
Plath, Kathrin ;
Yamanaka, Shinya .
CELL STEM CELL, 2009, 4 (03) :200-201
[2]   Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency [J].
Hanna, Jacob ;
Markoulaki, Styliani ;
Schorderet, Patrick ;
Carey, Bryce W. ;
Beard, Caroline ;
Wernig, Marius ;
Creyghton, Menno P. ;
Steine, Eveline J. ;
Cassady, John P. ;
Foreman, Ruth ;
Lengner, Christopher J. ;
Dausman, Jessica A. ;
Jaenisch, Rudolf .
CELL, 2008, 133 (02) :250-264
[3]   Reprogramming of a melanoma genome by nuclear transplantation [J].
Hochedlinger, K ;
Blelloch, R ;
Brennan, C ;
Yamada, Y ;
Kim, MJ ;
Chin, L ;
Jaenisch, R .
GENES & DEVELOPMENT, 2004, 18 (15) :1875-1885
[4]   Blasts from the past: New lessons in stem cell biology from chronic myelogenous leukemia [J].
Huntly, BJP ;
Gilliland, DG .
CANCER CELL, 2004, 6 (03) :199-201
[5]  
KAELIN WG, 2004, SCI STKE, pPE12
[6]   Oct4-Induced Pluripotency in Adult Neural Stem Cells [J].
Kim, Jeong Beom ;
Sebastiano, Vittorio ;
Wu, Guangming ;
Arauzo-Bravo, Marcos J. ;
Sasse, Philipp ;
Gentile, Luca ;
Ko, Kinarm ;
Ruau, David ;
Ehrich, Mathias ;
van den Boom, Dirk ;
Meyer, Johann ;
Huebner, Karin ;
Bernemann, Christof ;
Ortmeier, Claudia ;
Zenke, Martin ;
Fleischmann, Bernd K. ;
Zaehres, Holm ;
Schoeler, Hans R. .
CELL, 2009, 136 (03) :411-419
[7]   Isolation and characterization of a near-haploid human cell line [J].
Kotecki, M ;
Reddy, PS ;
Cochran, BH .
EXPERIMENTAL CELL RESEARCH, 1999, 252 (02) :273-280
[8]   Generation of induced pluripotent stem cells from human blood [J].
Loh, Yuin-Han ;
Agarwal, Suneet ;
Park, In-Hyun ;
Urbach, Achia ;
Huo, Hongguang ;
Heffner, Garrett C. ;
Kim, Kitai ;
Miller, Justine D. ;
Ng, Kitwa ;
Daley, George Q. .
BLOOD, 2009, 113 (22) :5476-5479
[9]   Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction [J].
Luo, Ji ;
Solimini, Nicole L. ;
Elledge, Stephen J. .
CELL, 2009, 136 (05) :823-837
[10]   Chronic myeloid leukaemia as a model of disease evolution in human cancer [J].
Melo, Junia V. ;
Barnes, David J. .
NATURE REVIEWS CANCER, 2007, 7 (06) :441-453